Study of Molecular Profile-Related Evidence to Determine Individualized Therapy for Advanced or Poor Prognosis Cancers

CompletedOBSERVATIONAL
Enrollment

506

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 17, 2020

Study Completion Date

December 1, 2022

Conditions
Cancer
Trial Locations (2)

57105

Avera Cancer Institute, Sioux Falls

92093

UCSD Moores Cancer Center, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Foundation Medicine

INDUSTRY

lead

University of California, San Diego

OTHER